key: cord-0786383-nguugq5n
authors: SAKOWICZ, Allie; AYALA, Alexander E.; UKEJE, Chideraa C.; WITTING, Celeste S.; GROBMAN, William A.; MILLER, Emily S.
title: Risk Factors for SARS-CoV2 Infection in Pregnant Women
date: 2020-08-17
journal: Am J Obstet Gynecol MFM
DOI: 10.1016/j.ajogmf.2020.100198
sha: 513d3d6e77b590610fa5189beb9a4ade9020e175
doc_id: 786383
cord_uid: nguugq5n

Abstract Background Risk factors for SARS-CoV2 infection in pregnancy remain poorly understood. Understanding populations at heightened risk of acquisition is essential to more effectively target outreach and prevention efforts. Objective To compare sociodemographic and clinical characteristics of pregnant women with and without SARS-CoV2 infection and, among those with SARS-CoV2, to compare characteristics of those who reported COVID-19 symptoms and those who were asymptomatic at diagnosis. Study Design This retrospective cohort study includes pregnant women who delivered or intended to deliver at Northwestern Memorial Hospital after initiation of a universal testing protocol on admission (April 8, 2020 - May 31, 2020). Women were dichotomized by whether they tested positive for SARS-CoV2. Among women who tested positive, women were further dichotomized by whether they endorsed symptoms of COVID-19. Bivariable analysis, and non-parametric tests of trend were used for analyses. Logistic regression was used to control for potential confounders as well as to examine effect modification between race and ethnicity and any other identified risk factors. Results During the study period, 1,418 women met inclusion criteria, of whom 101 (7.1%) tested positive for SARS-CoV2. Of the 101 women who tested positive, 77 (76.2%) were symptomatic at the time of diagnosis. Compared to women who tested negative for SARS-CoV2, women who tested positive were younger and were more likely to have public insurance, to identify as Black/African-American or Latina, to be unmarried, to be obese, have pre-existing pulmonary disease, and have living children. An increasing number of living children was associated with an increasing risk of SARS-CoV2 infection and this finding persisted after controlling for potential confounders. There was no effect modification between race or ethnicity and having living children with regard to the risk of infection. There were no significant differences identified between women who were symptomatic and asymptomatic. Conclusion Many risk factors for SARS-CoV2 infection in pregnancy are similar to the social and structural determinants of health that have been reported in the general population. The observed association between SARS-CoV2 infection and having children raises the possibility of children themselves as vectors of viral spread or behavior patterns of parents as mediators of acquisition.

Background: Risk factors for SARS-CoV2 infection in pregnancy remain poorly 27 understood. Understanding populations at heightened risk of acquisition is essential to 28 more effectively target outreach and prevention efforts. of community viral spread on a population level 9 . Epidemiologists have found that while 95 children are less likely to exhibit SARS-CoV2 symptoms compared to adults 10,11 , they 96 also have more subtle presentations 11-13 and may spread disease to family members at 97 home 14, 15 . On an individual level, these data suggest that families with children at home, 98 particularly families who are not able to physically distance, may be at higher risk of 99 SARS-CoV2 acquisition. As many pregnant women in the United States have young 100 children at home, they may be a particularly vulnerable population for SARS-CoV2 101 acquisition, but this association has not been previously evaluated. 102 103 Universal SARS-CoV2 testing among pregnant women represents an opportunity to 104 better understand epidemiologic risk factors. As our hospital is a large volume center 105 located in a high prevalence region of the United States, our objective was to leverage 106 data ascertained from our testing policies to characterize the epidemiology of SARS- index at delivery, tobacco use, and any identified maternal pre-existing disease (e.g., 148 diabetes, hypertension, pulmonary disease). Obstetric data included parity (e.g., term 149 births, preterm births, and living children). The systematic symptom assessment was 150 entered into the EHR in a form completed by the admitting nurse and was abstracted to 151 the database. Details of the SARS-CoV2 testing platform utilized, as well as test results, 152 were also abstracted. Data were entered into the research electronic data capture system 153 (REDCap) 16 and missing or aberrant data were re-reviewed by systematic assessment of 154 the database. The demographic characteristics of the cohort are presented in Table 1 . Compared to 188 women who tested negative, women who tested positive for SARS-CoV2 were younger 189 and more likely to be publicly insured, to identify with a racial or ethnic minority group, 190 and to be unmarried. In addition, women who tested positive for SARS-CoV2 were more 191 likely to be obese and to have a pre-existing pulmonary disease. In terms of obstetric 192 characteristics, women who tested positive for SARS-CoV2 were less likely to be 193 nulliparous and, accordingly, were more likely to have living children. 

Among women diagnosed with SARS-CoV2, 77 (76.2%) were symptomatic upon 212 presentation (Table 3) . Importantly, these data included epochs wherein only women with 213 overt symptoms of COVID-19 could be tested for SARS-CoV2. Accordingly, 76.2% is 214 not reflective of population level symptom prevalence. No significant differences 215 between women who presented with and without symptoms were found in terms of 216 maternal age, use of public insurance, nulliparity, number of living children, race, 217 ethnicity, marriage status, BMI at delivery, rates of obesity, tobacco use, presence of any 218 maternal chronic disease, rates of pre-existing diabetes, rates of hypertension, rates of 219 pulmonary disease, and rates of gestational diabetes. 

World Health Organization

COVID-19) in the U.S. Centers for Disease 348

Control and Prevention

Infections and Transmission in a Skilled Nursing Facility

Amid Ongoing COVID-19 Pandemic

Governor Cuomo Announces Results of Completed Antibody Testing Study of 356 15,000 People Showing 12.3 Percent of Population Has COVID-19 Antibodies 357

Cases With Non-respiratory Symptoms as the First Manifestation in Children

COVID-19 epidemic: Disease characteristics in children

Early Release)

Electronic Data Capture (REDCap) -A metadata-driven methodology and workflow 395 process for providing translational research informatics support

Disparities in influenza mortality and transmission related to sociodemographic 411 factors within Chicago in the pandemic of 1918

Virus Infections

Protecting health during COVID-19 and 421 beyond: A global examination of paid sick leave design in 193 countries

Examining Inequities Associated With 450

Changes in Obstetric and Gynecologic Care Delivery During the Coronavirus 451 Disease 2019 (COVID-19) Pandemic